Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Bain BJ, Gilliland DG, Horny H-P, Vardiman JW . Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1. In: Swerdlow S, Harris NL, Stein H, Jaffe ES, Theile J, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008, 68–73.

    Google Scholar 

  2. Jackson CC, Medeiros LJ, Miranda RN . 8p11 myeloproliferative syndrome: a review. Hum Pathol 2010; 41: 461–476.

    Article  CAS  Google Scholar 

  3. Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001; 98: 3778–3783.

    Article  CAS  Google Scholar 

  4. Murati A, Arnoulet C, Lafage-Pochitaloff M, Adelaide J, Derre M, Slama B et al. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion. Int J Oncol 2005; 26: 1485–1492.

    CAS  PubMed  Google Scholar 

  5. Haslam K, Langabeer SE, Kelly J, Coen N, O'Connell NM, Conneally E . Allogeneic hematopoietic stem cell transplantation for a BCR-FGFR1 myeloproliferative neoplasm presenting as acute lymphoblastic leukemia. Case Rep Hematol 2012; 2012: 620967.

    PubMed  PubMed Central  Google Scholar 

  6. Wakim JJ, Tirado CA, Chen W, Collins R . t(8;22)/BCR-FGFR1 myeloprolife-rative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leuk Res 2011; 35: e151–e153.

    Article  Google Scholar 

  7. Morishige S, Oku E, Takata Y, Kimura Y, Arakawa F, Seki R et al. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation. Acta Haematol 2013; 129: 83–89.

    Article  Google Scholar 

  8. Dolan M, Cioc A, Cross NC, Neglia JP, Tolar J . Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion. Pediatr Blood Cancer 2012; 59: 194–196.

    Article  Google Scholar 

  9. Chase A, Bryant C, Score J, Cross NC . Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome. Haematologica 2013; 98: 103–106.

    Article  CAS  Google Scholar 

  10. Ren M, Qin H, Ren R, Cowell JK . Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities. Leukemia 2013; 27: 32–40.

    Article  CAS  Google Scholar 

  11. Townsend W, Cross NC, Waghorn K, Somana K, Ramsay A, Thomson K et al. Clinical evidence for a graft-versus-tumour effect following allogenic HSCT fo t(8;13) atypical myeloproliferative disorder. Bone Marrow Transplant 2009; 44: 197–199.

    Article  CAS  Google Scholar 

  12. Richebourg S, Theisen O, Plantier I, Parry A, Soenen-Cornu V, Lepelley P et al. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia. Genes Chromosomes Cancer 2008; 47: 915–918.

    Article  CAS  Google Scholar 

  13. Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M et al. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 2001; 32: 302–310.

    Article  CAS  Google Scholar 

  14. Chase A, Grand FH, Cross NC . Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood 2007; 110: 3729–3734.

    Article  CAS  Google Scholar 

  15. Chen J, DeAngelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101: 14479–14484.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We express gratitude to Parveen Abidi and Larry Okumoto of the Stanford Hematology Division Tissue Bank for assistance with sample collection and processing, as well as Linda Gojenola from the Stanford Molecular Diagnostics Lab for assistance with DNA extraction. This work is supported by the Charles and Ann Johnson Foundation (JG).

Author Contributions

MSK, BCM, ASS, SA and JG provided care to the patient; RCJ, MDE and DAA performed hematopathologic evaluation of the case; CDB and AMC conducted FISH and cytogenetic studies; BL and JLZ performed all molecular diagnostic analyses. MSK, BL, BCM, RCJ, MDE, CDB, AMC, DAA, JLZ and JG analyzed the data. MSK and JG wrote the first draft of the manuscript. All the authors reviewed, provided input and approved the final draft of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Gotlib.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khodadoust, M., Luo, B., Medeiros, B. et al. Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia 30, 947–950 (2016). https://doi.org/10.1038/leu.2015.136

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2015.136

This article is cited by

Search

Quick links